We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,159
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.22%
2 Technology 4.92%
3 Industrials 4.28%
4 Consumer Discretionary 4.13%
5 Healthcare 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
7376
DELISTED
Apellis Pharmaceuticals
APLS
$247K ﹤0.01%
+11,267
New +$259K
BIS icon
7377
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
$247K ﹤0.01%
1,588
-437
-22% -$72.7K
ORAN
7378
CALL
DELISTED
Orange
ORAN
$247K ﹤0.01%
+14,800
New +$258K
DBKO
7379
DELISTED
Xtrackers MSCI South Korea Hedged Equity ETF
DBKO
$247K ﹤0.01%
8,540
-19,676
-70% -$609K
SYNT
7380
CALL
DELISTED
Syntel Inc
SYNT
$247K ﹤0.01%
7,700
-1,900
-20% -$56.8K
SBIO icon
7381
CALL
ALPS Medical Breakthroughs ETF
SBIO
$215M
$246K ﹤0.01%
6,600
-1,600
-20% -$58K
SLP icon
7382
Simulations Plus
SLP
$371M
$246K ﹤0.01%
+11,049
New +$209K
XNET
7383
CALL
Xunlei
XNET
$334M
$246K ﹤0.01%
23,000
-10,000
-30% -$124K
ZOES
7384
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
$246K ﹤0.01%
25,200
-15,100
-37% -$192K
DMC
7385
Del Monte Corp
DMC
$1.43B
$245K ﹤0.01%
5,507
-28,061
-84% -$1.31M
IMUX icon
7386
Immunic
IMUX
$219M
$245K ﹤0.01%
+89
New +$206K
KNDI
7387
CALL
Kandi Technologies Group
KNDI
$63M
$245K ﹤0.01%
57,700
+28,800
+100% +$145K
VHC icon
7388
CALL
VirnetX Holding Corp
VHC
$62.8M
$245K ﹤0.01%
3,605
-475
-12% -$30.9K
BAL
7389
CALL
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
$245K ﹤0.01%
+4,700
New +$248K
SXCP
7390
CALL
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$245K ﹤0.01%
16,300
+6,000
+58% +$97.3K
HZNP
7391
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$245K ﹤0.01%
14,793
-174,589
-92% -$2.66M
BSM icon
7392
PUT
Black Stone Minerals
BSM
$3.05B
$244K ﹤0.01%
+13,200
New +$237K
EPP icon
7393
PUT
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$244K ﹤0.01%
+5,300
New +$250K
ING icon
7394
ING
ING
$102B
$244K ﹤0.01%
17,030
-409,167
-96% -$6.5M
PINC
7395
PUT
DELISTED
Premier
PINC
$244K ﹤0.01%
+6,700
New +$222K
ECHO
7396
CALL
EchoStar
ECHO
$26.7B
$244K ﹤0.01%
+6,787
New +$277K
VRNT
7397
PUT
DELISTED
Verint Systems
VRNT
$244K ﹤0.01%
10,797
-11,385
-51% -$248K
MDRX
7398
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$244K ﹤0.01%
20,300
+2,100
+12% +$25.9K
OCLR
7399
CALL
DELISTED
Oclaro Inc.
OCLR
$244K ﹤0.01%
27,300
-15,800
-37% -$138K
ATRC icon
7400
CALL
AtriCure
ATRC
$2.25B
$243K ﹤0.01%
+9,000
New +$212K

Similar funds

Ken Griffin's Q2 2018 Portfolio in Review

As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.